Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML

Approval Number

SIN15419P

Drug Name

MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML

Product Name

MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML

Approval Date

February 8, 2018

Registrant

BAXTER HEALTHCARE (ASIA) PTE LTD

Licence Holder

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

Registrant

BAXTER HEALTHCARE (ASIA) PTE LTD

Licence Holder

BAXTER HEALTHCARE (ASIA) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS, INTRAMUSCULAR, RECTAL

Medical Information

ATC Code

N05CD08

ATC Item Name

midazolam

Manufacturer Information

Pharmaceutical Manufacturer

BAXTER HEALTHCARE (ASIA) PTE LTD

Manufacturers

Baxter Pharmaceuticals India Private Limited

Active Ingredients

Ingredient Name

Midazolam HCl 5.56 mg eqv Midazolam

Strength

5mg/ml

Drug MonographMidazolam

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy